The Form Bio leadership team includes (from left) Andrew Busey, co-CEO; Brandi Cantarel, director of bioinformatics; Kent Wakeford, co-CEO; Claire Aldridge, chief strategy officer; and Ben Lamm, co-founder. [Photo: John Davidson/Form Bio]
Dallas-based Colossal Biosciences, the de-extinction company behind plans to bring back the woolly mammoth and thylacine, developed its own software solution "after reviewing everything available on the market." Now it's sharing the platform with the launch of Form Bio.
The spinout's technology tools can help drive the “entire molecular revolution” that is occurring in the life sciences and biotech space, in addition to bolstering the Lone Star state as a hub for the industry, says Chief Strategy Officer Claire Aldridge.
